Back
PepsiCo Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
39
PEP
PepsiCo
Last Price:
167.28
Seasonality Move:
0.01%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
39
PepsiCo (PEP)
is a Sell
Is PepsiCo a Buy, Sell or Hold?
- The current PepsiCo [PEP] share price is $167.30. The Score for PEP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- PEP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PEP Stock Price Chart
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
PEP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.7 | Sell |
| Relative Strength Index (14 RSI): | 41.25 | Sell |
| Chaikin Money Flow: | -2237184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (165.91 - 178.51) | Sell |
| Bollinger Bands (100): | (166.14 - 176.26) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | 722527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.99 - 42.29) | Sell |
| Bollinger Bands (100): | (41.03 - 48.83) | Sell |
PEP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 165.32 | Buy |
| 20-day SMA: | 169.83 | Sell |
| 50-day SMA: | 173.55 | Sell |
| 200-day SMA: | 169.63 | Sell |
| 8-day EMA: | 166.73 | Buy |
| 20-day EMA: | 169.38 | Sell |
| 50-day EMA: | 171.64 | Sell |
| 200-day EMA: | 172.01 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.38 | Sell |
| 20-day SMA: | 40.41 | Sell |
| 50-day SMA: | 41.94 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.76 | Sell |
| 20-day EMA: | 40.54 | Sell |
| 50-day EMA: | 42.03 | Sell |
| 200-day EMA: | 43.46 | Sell |
PepsiCo Earnings Growth & PEP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.61 per share, and an increase next year of $0.66 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
PepsiCo Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||